143 related articles for article (PubMed ID: 23091890)
1. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors.
Lee WS; Park ES; Kim DH; Kim TH; Lee HH; Chung SH
Eur J Gynaecol Oncol; 2012; 33(4):358-62. PubMed ID: 23091890
[TBL] [Abstract][Full Text] [Related]
2. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
[TBL] [Abstract][Full Text] [Related]
3. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A
J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
[TBL] [Abstract][Full Text] [Related]
5. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27.
Gao L; Huang S; Ren W; Zhao L; Li J; Zhi K; Zhang Y; Qi H; Huang C
Med Oncol; 2012 Dec; 29(4):2499-504. PubMed ID: 22311264
[TBL] [Abstract][Full Text] [Related]
6. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
7. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.
Pan Y; Zhang Q; Tian L; Wang X; Fan X; Zhang H; Claret FX; Yang H
Cancer Res; 2012 Apr; 72(7):1890-900. PubMed ID: 22350412
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
[TBL] [Abstract][Full Text] [Related]
9. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
10. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
Giurgea LN; Ungureanu C; Mihailovici MS
Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
[TBL] [Abstract][Full Text] [Related]
12. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis.
Kim TH; Lee HH; Chung SH; Park J; Lee A
Arch Gynecol Obstet; 2015 Aug; 292(2):377-81. PubMed ID: 25666480
[TBL] [Abstract][Full Text] [Related]
13. JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.
Wang Y; Yu YN; Song S; Li TJ; Xiang JY; Zhang H; Lu MD; Ji F; Hu LQ
J Cancer Res Clin Oncol; 2014 Jun; 140(6):969-78. PubMed ID: 24671224
[TBL] [Abstract][Full Text] [Related]
14. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions.
Ivan D; Diwan AH; Esteva FJ; Prieto VG
Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004
[TBL] [Abstract][Full Text] [Related]
16. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma.
Chen L; Yuan D; Wang GL; Wang Y; Wu YY; Zhu J
J Korean Med Sci; 2010 Oct; 25(10):1438-42. PubMed ID: 20890423
[TBL] [Abstract][Full Text] [Related]
18. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
[TBL] [Abstract][Full Text] [Related]
20. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
